Persistence of clinical and serologic activity in patients with systemic lupus erythematosus undergoing peritoneal dialysis☆
References (29)
- et al.
Host responses to hepatitis B infection in patients in a chronic hemodialysis unit
Kidney Int
(1977) - et al.
Tuberculosis in patients undergoing maintenance hemodialysis
Am J Med
(1979) - et al.
T cell subsets and cellular immunity in end-stage renal disease
Am J Med
(1983) - et al.
Prolongation of skin allograft survival and inhibition of graft versus host reaction in rodents treated with “middle molecules”
Cell Immun
(1977) - et al.
Late-stage lupus nephropathy
J Rheumatol
(1974) - et al.
The longterm clinic course of systemic lupus erythematosus in end-stage renal disease
N Engl J Med
(1983) - et al.
Regression of clinical and immunological expression of systemic lupus erythematosus consequent to the development of uremia
Kidney Int
(1979) - et al.
“End-stage” lupus nephritis: clinical course to and outcome on dialysis: experience with 39 patients
Medicine (Baltimore)
(1981) - et al.
End-stage renal failure in systemic lupus erythematosus with nephritis
Clin Nephrol
(1984) - et al.
Chronic hemodialysis in end-stage lupus nephritis: changes of clinical and serological activities
Artif Organs
(1984)
The clinical course of end-stage renal disease in systemic lupus erythematosus
Arch Intern Med
(1983)
Preliminary criteria for the classification of systemic lupus erythematosus
Bull Rheum Dis
(1971)
Letter to the editor
N Engl J Med
(1983)
Reactivation of systemic lupus in three patients undergoing CAPD
Periton Dial Bull
(1986)
Cited by (40)
Assessment of lupus activity for Egyptian patients on regular hemodialysis, is there a need for prolonged immunosuppressive therapy?
2019, Egyptian RheumatologistCitation Excerpt :Correia et al. also reported that 33% of cases had evidences of active SLE [27]. Rodby et al reported 8 clinical flares in 7 patients [28] while Goo et al retrospectively studied 45 patients with SLE and ESRD and observed that after the first year of dialysis, serological markers of the disease were present in 80%; in the second and third years, they remained active in 60% and 52%, respectively [24]. In another case control study, 50% developed lupus flares after HD [29].
Complementary and alternative medications, specialized and niche therapies
2018, Dubois' Lupus Erythematosus and Related SyndromesConsensus of the Brazilian Society of Rheumatology for the diagnosis, management and treatment of lupus nephritis
2015, Revista Brasileira de ReumatologiaSpecialized Treatment Approaches and Niche Therapies for Lupus Subsets
2012, Dubois' Lupus Erythematosus and Related Syndromes: Eighth EditionLupus nephritis
2012, Nephrology SecretsLupus nephritis
2011, Nephrology Secrets
- ☆
From the Section of Nephrology, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois.
Copyright © 1997 Published by Excerpta Medica Inc.